{"@context":{"owl":"http://www.w3.org/2002/07/owl#","bibo":"http://purl.org/ontology/bibo/","foaf":"http://xmlns.com/foaf/0.1/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/"},"@id":"https://ci.nii.ac.jp/ncid/BA72101368.json","@graph":[{"@id":"https://ci.nii.ac.jp/ncid/BA72101368#entity","@type":"bibo:Book","foaf:isPrimaryTopicOf":{"@id":"https://ci.nii.ac.jp/ncid/BA72101368.json"},"dc:title":[{"@value":"Oral contraceptives"}],"dc:publisher":[{"@value":"U.S. Govt. Print. Off."}],"dcterms:extent":"v.","cinii:size":"24 cm","dc:language":"eng","dc:date":"1970","cinii:ncid":"BA72101368","cinii:ownerCount":"1","foaf:maker":[{"@id":"https://ci.nii.ac.jp/author/DA02058351#entity","@type":"foaf:Person","foaf:name":[{"@value":"United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly"}]}],"bibo:owner":[{"@id":"https://ci.nii.ac.jp/library/FA002473","@type":"foaf:Organization","foaf:name":"名古屋大学 経済学 図書室","rdfs:seeAlso":{"@id":"https://m-opac.nul.nagoya-u.ac.jp/iwjs0023opc/ufirdi.do?ufi_target=ctlsrh&ncid=BA72101368&initFlg=_RESULT_SET_NOTBIB"}}],"prism:publicationDate":["1970"],"cinii:note":["Ninety-first congress, second session","v. 2. February 24, 25; March 3 and 4, 1970. -- v. 3. Appendixex"],"dcterms:isPartOf":[{"@id":"https://ci.nii.ac.jp/ncid/BA37116800#entity","dc:title":"Competitive problems in the drug industry : hearings before the Subcommittee on Monopoly of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session [-Ninety-fifth Congress, first session], on present status of competition in the pharmaceutical industry, pt. 16-17","@type":"bibo:Book"}],"dcterms:hasPart":[{"dc:title":"v. 2"},{"dc:title":"v. 3"}]}]}